Clearance, translocation, and excretion of beryllium following acute inhalation of beryllium oxide by beagle dogs. 1990

G L Finch, and J A Mewhinney, and M D Hoover, and A F Eidson, and P J Haley, and D E Bice
Inhalation Toxicology Research Institute, Lovelace Biomedical and Environmental Research Institute, Albuquerque, New Mexico 87185.

Beagle dogs inhaled radiolabeled beryllium oxide (7BeO) particles that were calcined at either 500 or 1000 degrees C, resulting in either high (mean of 50 micrograms/kg body wt) or low (mean of 17 micrograms/kg body wt) initial lung burdens (ILBs) of both preparations of BeO. Levels of beryllium in whole body, tissue, and excreta were measured by external gamma-ray counting. Dogs were euthanized in pairs at 8, 32, 64, and 180 days after exposure to determine beryllium distribution in tissues. Beryllium oxide calcined at 1000 degrees C was retained more tenaciously in the lungs (62% of the ILB retained at 180 days after exposure) than BeO calcined at 500 degrees C (14% of the ILB retained at 180 days after exposure). Most of the beryllium that was cleared from the lungs and not excreted was translocated to the tracheobronchial lymph nodes, skeleton, liver, and blood. More beryllium was translocated to the skeleton and liver at 180 days after inhalation of BeO prepared at 500 degrees C than at 1000 degrees C. The predominant mode of excretion at early times after exposure was through the feces, with urinary excretion assuming predominance at later times. These data are important for interpreting the toxic effects of beryllium in the exposed dogs. Furthermore, because little is known concerning the retention and clearance of inhaled beryllium in man, these results provide information that may be used to understand the disposition of beryllium in accidentally exposed humans.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D001822 Body Burden The total amount of a chemical, metal or radioactive substance present at any time after absorption in the body of man or animal. Body Burdens,Burden, Body,Burdens, Body
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001608 Beryllium An element with the atomic symbol Be, atomic number 4, and atomic weight 9.01218. Short exposure to this element can lead to a type of poisoning known as BERYLLIOSIS.

Related Publications

G L Finch, and J A Mewhinney, and M D Hoover, and A F Eidson, and P J Haley, and D E Bice
January 1966, BNWL [reports]. U.S. Atomic Energy Commission,
G L Finch, and J A Mewhinney, and M D Hoover, and A F Eidson, and P J Haley, and D E Bice
November 1982, Health physics,
G L Finch, and J A Mewhinney, and M D Hoover, and A F Eidson, and P J Haley, and D E Bice
May 1968, BNWL [reports]. U.S. Atomic Energy Commission,
G L Finch, and J A Mewhinney, and M D Hoover, and A F Eidson, and P J Haley, and D E Bice
May 1975, Health physics,
G L Finch, and J A Mewhinney, and M D Hoover, and A F Eidson, and P J Haley, and D E Bice
January 1966, BNWL [reports]. U.S. Atomic Energy Commission,
G L Finch, and J A Mewhinney, and M D Hoover, and A F Eidson, and P J Haley, and D E Bice
November 1986, Health physics,
G L Finch, and J A Mewhinney, and M D Hoover, and A F Eidson, and P J Haley, and D E Bice
January 1966, BNWL [reports]. U.S. Atomic Energy Commission,
G L Finch, and J A Mewhinney, and M D Hoover, and A F Eidson, and P J Haley, and D E Bice
November 1967, Fission product inhalation project [technical progress report]. Lovelace Foundation for Medical Education and Research,
G L Finch, and J A Mewhinney, and M D Hoover, and A F Eidson, and P J Haley, and D E Bice
May 1951, A.M.A. archives of pathology,
G L Finch, and J A Mewhinney, and M D Hoover, and A F Eidson, and P J Haley, and D E Bice
October 1985, Radiation research,
Copied contents to your clipboard!